Cogent Biosciences
COGT41.3604.52% ( +1.790 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Cogent Biosciences(COGT) predict that the EBIT is -103.61 M (-38.27%), Miss estimate;the EPS is -0.53 (-1.92%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITMiss expectations
-0.10B38.27%
-0.09B26.69%
-0.01B11.58%
EPSExceed expectations
-0.531.92%
-0.54094.03%
+0.01092.11%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf